Literature DB >> 8252725

Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage.

W Wasowicz1, J Nève, A Peretz.   

Abstract

A simple, reliable, and reproducible fluorometric method for measuring thiobarbituric acid-reactive substances (TBARS) in serum is proposed, based on the reaction between malondialdehyde (MDA) and thiobarbituric acid. Formation of TBARS was complete at pH 2.4-2.6, but extraction with n-butanol proved complete only at lower pH, i.e., 1.6-1.7. Analytical recoveries of MDA added to serum were 94%-101%; within- and between-run CVs were 2.4-3.6% and 4.6-5.5%; and the detection limit for TBARS in serum was 0.10 mumol/L. Optimized conditions included: (a) collection of either serum or heparinized plasma, (b) preservation from in vitro autoxidation by glutathione and EDTA, and (c) storage at -20 degrees C up to 35 days. The mean (+/- SD) TBARS concentration in 47 healthy adults was 1.01 (0.21) mumol/L; no sex-related difference was observed. Higher concentrations were measured in patients with renal insufficiency undergoing hemodialysis and in patients with insulin-dependent diabetes, chronic pancreatitis, or liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252725

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  107 in total

1.  Plasma malondialdehyde and nitric oxide levels in age related macular degeneration.

Authors:  Y Totan; O Cekiç; M Borazan; E Uz; S Sögüt; O Akyol
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

2.  Nitric oxide, lipid peroxidation and total thiol levels in acute appendicitis.

Authors:  Fatma Meriç Yilmaz; Gülsen Yilmaz; Mehmet Fatih Erol; Seyfettin Köklü; Doğan Yücel
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

4.  Examination of electric field effects on tissues by using back propagation neural network.

Authors:  Göknur Güler; Firat Hardalaç; Aysel Aricioğlu
Journal:  J Med Syst       Date:  2005-12       Impact factor: 4.460

5.  Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis.

Authors:  A Van Gossum; P Closset; E Noel; M Cremer; J Neve
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

6.  The effect of arsenic on some antioxidant enzyme activities and lipid peroxidation in various tissues of mirror carp (Cyprinus carpio carpio).

Authors:  Sayit Altikat; Kazim Uysal; Halil Isa Kuru; Mustafa Kavasoglu; Gul Nihan Ozturk; Aysegul Kucuk
Journal:  Environ Sci Pollut Res Int       Date:  2014-04-27       Impact factor: 4.223

7.  Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Authors:  Bryan D Maliken; James E Nelson; Heather M Klintworth; Mary Beauchamp; Matthew M Yeh; Kris V Kowdley
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

8.  Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats.

Authors:  Emin Ozbek; Yusuf Ozlem Ilbey; Abdulmuttalip Simsek; Mustafa Cekmen; Fatih Mete; Adnan Somay
Journal:  Int Urol Nephrol       Date:  2009-09-25       Impact factor: 2.370

9.  Local and systemic oxidative stress status in chronic obstructive pulmonary disease patients.

Authors:  Mian Zeng; Yue Li; Yujie Jiang; Guifang Lu; Xiaomei Huang; Kaipan Guan
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

10.  Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study.

Authors:  Nihayet Bayraktar; Suleyman Kilic; Mehmet Refik Bayraktar; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.